ID: ALA5219520

Max Phase: Preclinical

Molecular Formula: C16H12FN3O2S

Molecular Weight: 329.36

Associated Items:

Representations

Canonical SMILES:  O=C(NC1CC1)c1nn(-c2ccc(F)cc2)c(=O)c2cscc12

Standard InChI:  InChI=1S/C16H12FN3O2S/c17-9-1-5-11(6-2-9)20-16(22)13-8-23-7-12(13)14(19-20)15(21)18-10-3-4-10/h1-2,5-8,10H,3-4H2,(H,18,21)

Standard InChI Key:  AJHFGZSLSJQTGC-UHFFFAOYSA-N

Associated Targets(Human)

Microtubule-associated protein tau 95507 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 329.36Molecular Weight (Monoisotopic): 329.0634AlogP: 2.48#Rotatable Bonds: 3
Polar Surface Area: 63.99Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.53CX Basic pKa: CX LogP: 2.48CX LogD: 2.48
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -2.02

References

1. Callis TB, Garrett TR, Montgomery AP, Danon JJ, Kassiou M..  (2022)  Recent Scaffold Hopping Applications in Central Nervous System Drug Discovery.,  65  (20.0): [PMID:36206553] [10.1021/acs.jmedchem.2c00969]

Source